speb/financial-data huggingface dataset:
CLYM cash_flow (annual, 2024-12-31) — Investing Cash Flow: -121092000.00
CLYM balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 61610000.00
CLYM balance_sheet (annual, 2024-12-31) — Investments And Advances: 61610000.00
CLYM cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 119750000.00
CLYM cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
CLYM balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 375000.00
CLYM balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 375000.00
CLYM cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 119750000.00
CLYM cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
CLYM cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -42000.00
CLYM income_statement (annual, 2024-12-31) — Net Income: -73897000.00
CLYM income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -73897000.00
CLYM income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -73897000.00
CLYM income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -73897000.00
CLYM income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -73897000.00
CLYM cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -73897000.00
CLYM income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -73897000.00
CLYM income_statement (annual, 2024-12-31) — Net Interest Income: 8132000.00
CLYM cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -111447000.00
CLYM income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 8132000.00
CLYM cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -9645000.00
CLYM cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: 0.00
CLYM balance_sheet (annual, 2024-12-31) — Net PPE: 689000.00
CLYM cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 0.00
CLYM balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 211881000.00
CLYM income_statement (annual, 2024-12-31) — Normalized EBITDA: 21307000.00
CLYM income_statement (annual, 2024-12-31) — Normalized Income: -22229000.00
CLYM cash_flow (annual, 2024-12-31) — Operating Cash Flow: -15562000.00
CLYM cash_flow (annual, 2024-12-31) — Operating Gains Losses: -42000.00
CLYM income_statement (annual, 2024-12-31) — Operating Income: -30361000.00
CLYM income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
CLYM balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 67255434.00
CLYM balance_sheet (annual, 2024-12-31) — Other Current Assets: 256000.00
CLYM balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 256000.00
CLYM balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 89000.00
CLYM balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 89000.00
CLYM balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 23000.00
CLYM income_statement (annual, 2024-12-31) — Other Gand A: 16025000.00
CLYM income_statement (annual, 2024-12-31) — Other Income Expense: -51668000.00
CLYM cash_flow (annual, 2024-12-31) — Other Non Cash Items: 51879000.00
CLYM balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 16000.00
CLYM balance_sheet (annual, 2024-12-31) — Other Properties: 689000.00
CLYM balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 63690000.00
CLYM income_statement (annual, 2024-12-31) — Other Special Charges: 51659000.00
CLYM income_statement (quarterly, 2024-12-31) — Other Special Charges: 0.00
CLYM balance_sheet (annual, 2024-12-31) — Payables: 705000.00
CLYM balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 4685000.00
CLYM balance_sheet (annual, 2024-12-31) — Prepaid Assets: 3953000.00
CLYM income_statement (annual, 2024-12-31) — Pretax Income: -73897000.00
CLYM cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 10979000.00
CLYM cash_flow (annual, 2024-12-31) — Purchase Of Investment: -132197000.00
CLYM cash_flow (annual, 2024-12-31) — Purchase Of PPE: 0.00
CLYM balance_sheet (annual, 2024-12-31) — Receivables: 1119000.00
CLYM balance_sheet (quarterly, 2024-12-31) — Receivables: 1119000.00
CLYM income_statement (annual, 2024-12-31) — Reconciled Depreciation: 0.00
CLYM income_statement (annual, 2024-12-31) — Research And Development: 14336000.00
CLYM balance_sheet (annual, 2024-12-31) — Retained Earnings: -229876000.00
CLYM cash_flow (annual, 2024-12-31) — Sale Of Investment: 20750000.00
CLYM income_statement (annual, 2024-12-31) — Selling General And Administration: 16025000.00
CLYM balance_sheet (annual, 2024-12-31) — Share Issued: 67255434.00
CLYM income_statement (annual, 2024-12-31) — Special Income Charges: -51659000.00
CLYM income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
CLYM cash_flow (annual, 2024-12-31) — Stock Based Compensation: 5557000.00
CLYM balance_sheet (annual, 2024-12-31) — Stockholders Equity: 211881000.00
CLYM balance_sheet (annual, 2024-12-31) — Tangible Book Value: 211881000.00
CLYM income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CLYM income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
CLYM balance_sheet (annual, 2024-12-31) — Taxes Receivable: 0.00
CLYM balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 0.00
CLYM balance_sheet (annual, 2024-12-31) — Total Assets: 217187000.00
CLYM balance_sheet (annual, 2024-12-31) — Total Capitalization: 211881000.00
CLYM balance_sheet (annual, 2024-12-31) — Total Debt: 532000.00
CLYM balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 211881000.00
CLYM income_statement (annual, 2024-12-31) — Total Expenses: 30361000.00
CLYM balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 5306000.00
CLYM balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 62315000.00
CLYM balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 375000.00
CLYM income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -82020000.00
CLYM income_statement (annual, 2024-12-31) — Total Unusual Items: -51668000.00
CLYM income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -51668000.00
CLYM balance_sheet (annual, 2024-12-31) — Working Capital: 149941000.00
CLYM income_statement (quarterly, 2025-03-31) — +Operating Expense: 23018000.00
CLYM income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
CLYM balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 777000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Accrued Interest Receivable: 1366000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 443749000.00
CLYM cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -669000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 99783000.00
CLYM income_statement (quarterly, 2025-03-31) — Basic Average Shares: 67462450.00
CLYM income_statement (quarterly, 2025-03-31) — Basic EPS: -0.31
CLYM cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 87229000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 474000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Capital Stock: 7000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 29020000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 98062000.00
CLYM cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 0.00
CLYM cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -42751000.00
CLYM cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -15434000.00
CLYM cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 72000.00
CLYM cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 2035000.00
CLYM cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -10000.00
CLYM cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -59000.00
CLYM cash_flow (quarterly, 2025-03-31) — Change In Payable: 72000.00
CLYM cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 2107000.00
CLYM cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 1893000.00
CLYM cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 3931000.00
CLYM cash_flow (quarterly, 2025-03-31) — Changes In Cash: -58185000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Common Stock: 7000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 193385000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 6104000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Current Assets: 100280000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 155000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 155000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 7036000.00
CLYM cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 0.00
CLYM cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 0.00
CLYM income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 67462450.00
CLYM income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.31
CLYM income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -20781000.00
CLYM income_statement (quarterly, 2025-03-31) — EBIT: -23018000.00
CLYM income_statement (quarterly, 2025-03-31) — EBITDA: -23018000.00
CLYM cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -24000.00
CLYM cash_flow (quarterly, 2025-03-31) — End Cash Position: 29020000.00
CLYM cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 0.00
CLYM cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -15434000.00
CLYM income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -50000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 286000.00
CLYM income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 5691000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Gross PPE: 451000.00
CLYM income_statement (quarterly, 2025-03-31) — Interest Income: 2287000.00
CLYM income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 2287000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Invested Capital: 193385000.00
CLYM cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -42751000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 99783000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 99783000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 319000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 319000.00
CLYM cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 24000.00
CLYM income_statement (quarterly, 2025-03-31) — Net Income: -20781000.00
CLYM income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -20781000.00
CLYM income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -20781000.00
CLYM income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -20781000.00
CLYM income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -20781000.00
CLYM cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -20781000.00
CLYM income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -20781000.00
CLYM income_statement (quarterly, 2025-03-31) — Net Interest Income: 2287000.00
CLYM cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -42751000.00
CLYM income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 2287000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Net PPE: 451000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 193385000.00
CLYM income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -22968000.00
CLYM income_statement (quarterly, 2025-03-31) — Normalized Income: -20731000.00
CLYM cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -15434000.00
CLYM cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 24000.00
CLYM income_statement (quarterly, 2025-03-31) — Operating Income: -23018000.00
CLYM income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
CLYM balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 67575767.00
CLYM balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 114000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 286000.00
CLYM income_statement (quarterly, 2025-03-31) — Other Gand A: 5691000.00
CLYM income_statement (quarterly, 2025-03-31) — Other Income Expense: -50000.00
CLYM cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 39000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 226000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Other Properties: 451000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 69042000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Payables: 777000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 6881000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 738000.00
CLYM income_statement (quarterly, 2025-03-31) — Pretax Income: -20781000.00
CLYM cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
CLYM cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -58751000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Receivables: 1366000.00
CLYM income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 0.00
CLYM income_statement (quarterly, 2025-03-31) — Research And Development: 17327000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -250657000.00
CLYM cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 16000000.00
CLYM income_statement (quarterly, 2025-03-31) — Selling General And Administration: 5691000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Share Issued: 67575767.00
CLYM cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 2022000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 193385000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 193385000.00
CLYM income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CLYM income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
CLYM balance_sheet (quarterly, 2025-03-31) — Total Assets: 200740000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 193385000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Total Debt: 474000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 193385000.00
CLYM income_statement (quarterly, 2025-03-31) — Total Expenses: 23018000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 7355000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 100460000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 319000.00
CLYM income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -23018000.00
CLYM income_statement (quarterly, 2025-03-31) — Total Unusual Items: -50000.00
CLYM income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -50000.00
CLYM balance_sheet (quarterly, 2025-03-31) — Working Capital: 93244000.00
CLYM income_statement (quarterly, 2025-06-30) — +Operating Expense: 10677000.00
CLYM income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
CLYM balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 946000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 444762000.00
CLYM cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -571000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 102702000.00
CLYM income_statement (quarterly, 2025-06-30) — Basic Average Shares: 67585121.00
CLYM income_statement (quarterly, 2025-06-30) — Basic EPS: -0.13
CLYM cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 29020000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 639000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Capital Stock: 7000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 22682000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 84703000.00
CLYM cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 0.00
CLYM cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 4786000.00
CLYM cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -11148000.00
CLYM cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 93000.00
CLYM cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -1091000.00
CLYM cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -1342000.00
CLYM cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -50000.00
CLYM cash_flow (quarterly, 2025-06-30) — Change In Payable: 93000.00
CLYM cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -998000.00
CLYM cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -621000.00
CLYM cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -3011000.00
CLYM cash_flow (quarterly, 2025-06-30) — Changes In Cash: -6362000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Common Stock: 7000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 185764000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 5000000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Current Assets: 87384000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 222000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 222000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 6205000.00
CLYM cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 38000.00
CLYM cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 38000.00
CLYM income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 67585121.00
CLYM income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.13
CLYM income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -8666000.00
CLYM income_statement (quarterly, 2025-06-30) — EBIT: -10677000.00
CLYM income_statement (quarterly, 2025-06-30) — EBITDA: -10639000.00
CLYM cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 24000.00
CLYM cash_flow (quarterly, 2025-06-30) — End Cash Position: 22682000.00
CLYM cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 0.00
CLYM cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -11225000.00
CLYM income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -162000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 318000.00
CLYM income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 4102000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Gross PPE: 932000.00
CLYM income_statement (quarterly, 2025-06-30) — Interest Income: 2173000.00
CLYM income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 2173000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Invested Capital: 185764000.00
CLYM cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 4786000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 102702000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 102702000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 417000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 417000.00
CLYM cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 0.00
CLYM income_statement (quarterly, 2025-06-30) — Net Income: -8666000.00
CLYM income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -8666000.00
CLYM income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -8666000.00
CLYM income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -8666000.00
CLYM income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -8666000.00
CLYM cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -8666000.00
CLYM income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -8666000.00
CLYM income_statement (quarterly, 2025-06-30) — Net Interest Income: 2173000.00
CLYM cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 4863000.00
CLYM income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 2173000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Net PPE: 932000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 185764000.00
CLYM income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -10477000.00
CLYM income_statement (quarterly, 2025-06-30) — Normalized Income: -8504000.00
CLYM cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -11148000.00
CLYM cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 0.00
CLYM income_statement (quarterly, 2025-06-30) — Operating Income: -10677000.00
CLYM income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
CLYM balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 67764100.00
CLYM balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 37000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 318000.00
CLYM income_statement (quarterly, 2025-06-30) — Other Gand A: 4102000.00
CLYM income_statement (quarterly, 2025-06-30) — Other Income Expense: -162000.00
CLYM cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 49000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 1368000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Other Properties: 932000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 62021000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Payables: 946000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 5946000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 2681000.00
CLYM income_statement (quarterly, 2025-06-30) — Pretax Income: -8666000.00
CLYM cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
CLYM cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -20619000.00
CLYM income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 38000.00
CLYM income_statement (quarterly, 2025-06-30) — Research And Development: 6575000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -259323000.00
CLYM cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 25482000.00
CLYM income_statement (quarterly, 2025-06-30) — Selling General And Administration: 4102000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Share Issued: 67764100.00
CLYM cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 1013000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 185764000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 185764000.00
CLYM income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CLYM income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
CLYM balance_sheet (quarterly, 2025-06-30) — Total Assets: 192386000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 185764000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Total Debt: 639000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 185764000.00
CLYM income_statement (quarterly, 2025-06-30) — Total Expenses: 10677000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 6622000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 105002000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 417000.00
CLYM income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -10677000.00
CLYM income_statement (quarterly, 2025-06-30) — Total Unusual Items: -162000.00
CLYM income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -162000.00
CLYM balance_sheet (quarterly, 2025-06-30) — Working Capital: 81179000.00
CLYM income_statement (quarterly, 2025-09-30) — +Operating Expense: 14892000.00
CLYM income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
CLYM balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 477000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 448738000.00
CLYM cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -523000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 88930000.00
CLYM income_statement (quarterly, 2025-09-30) — Basic Average Shares: 68003248.00
CLYM income_statement (quarterly, 2025-09-30) — Basic EPS: -0.19
CLYM cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 22682000.00
CLYM cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -109000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 580000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Capital Stock: 7000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 25803000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 86901000.00
CLYM cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 0.00
CLYM cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 15260000.00
CLYM cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -12139000.00
CLYM cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -393000.00
CLYM cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -792000.00
CLYM cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -162000.00
CLYM cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -59000.00
CLYM cash_flow (quarterly, 2025-09-30) — Change In Payable: -393000.00
CLYM cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -1185000.00
CLYM cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -1382000.00
CLYM cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -2788000.00
CLYM cash_flow (quarterly, 2025-09-30) — Changes In Cash: 3121000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Common Stock: 7000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 177003000.00
CLYM cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
CLYM balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 4167000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Current Assets: 90964000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 228000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 228000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 4949000.00
CLYM cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 29000.00
CLYM cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 29000.00
CLYM income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 68003248.00
CLYM income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.19
CLYM income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -12888000.00
CLYM income_statement (quarterly, 2025-09-30) — EBIT: -14892000.00
CLYM income_statement (quarterly, 2025-09-30) — EBITDA: -14863000.00
CLYM cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 0.00
CLYM cash_flow (quarterly, 2025-09-30) — End Cash Position: 25803000.00
CLYM cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 0.00
CLYM cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -12248000.00
CLYM income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -33000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 469000.00
CLYM income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 5819000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Gross PPE: 880000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Invested Capital: 177003000.00
CLYM cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 15260000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 88930000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 88930000.00
CLYM cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
CLYM balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 352000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 352000.00
CLYM cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CLYM cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -1000.00
CLYM income_statement (quarterly, 2025-09-30) — Net Income: -12888000.00
CLYM income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -12888000.00
CLYM income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -12888000.00
CLYM income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -12888000.00
CLYM income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -12888000.00
CLYM cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -12888000.00
CLYM income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -12888000.00
CLYM cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 15369000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Net PPE: 880000.00
CLYM cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -109000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 177003000.00
CLYM income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -14830000.00
CLYM income_statement (quarterly, 2025-09-30) — Normalized Income: -12855000.00
CLYM cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -12139000.00
CLYM cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -1000.00
CLYM income_statement (quarterly, 2025-09-30) — Operating Income: -14892000.00
CLYM income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
CLYM balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 68184435.00
CLYM balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 77000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 469000.00
CLYM income_statement (quarterly, 2025-09-30) — Other Gand A: 5819000.00
CLYM income_statement (quarterly, 2025-09-30) — Other Income Expense: 2004000.00
CLYM cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 56000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 1530000.00
CLYM income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 2037000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Other Properties: 880000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 61098000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Payables: 477000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 4644000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 4063000.00
CLYM income_statement (quarterly, 2025-09-30) — Pretax Income: -12888000.00
CLYM cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
CLYM cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -23712000.00
CLYM cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -109000.00
CLYM income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 29000.00
CLYM income_statement (quarterly, 2025-09-30) — Research And Development: 9073000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -272211000.00
CLYM cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 39081000.00
CLYM income_statement (quarterly, 2025-09-30) — Selling General And Administration: 5819000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Share Issued: 68184435.00
CLYM income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
CLYM cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 3976000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 177003000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 177003000.00
CLYM income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CLYM income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
CLYM balance_sheet (quarterly, 2025-09-30) — Total Assets: 182304000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 177003000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Total Debt: 580000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 177003000.00
CLYM income_statement (quarterly, 2025-09-30) — Total Expenses: 14892000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 5301000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 91340000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 352000.00
CLYM income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -14892000.00
CLYM income_statement (quarterly, 2025-09-30) — Total Unusual Items: -33000.00
CLYM income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -33000.00
CLYM balance_sheet (quarterly, 2025-09-30) — Working Capital: 86015000.00
CLYM income_statement (annual, 2025-12-31) — +Operating Expense: 67883000.00
CLYM income_statement (quarterly, 2025-12-31) — +Operating Expense: 19296000.00
CLYM income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
CLYM income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
CLYM balance_sheet (annual, 2025-12-31) — Accounts Payable: 2269000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 2269000.00
CLYM balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 449762000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 449762000.00
CLYM cash_flow (annual, 2025-12-31) — Amortization Of Securities: -2274000.00
CLYM cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -511000.00
CLYM balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 59572000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 59572000.00
CLYM income_statement (annual, 2025-12-31) — Basic Average Shares: 47766338.00
CLYM income_statement (quarterly, 2025-12-31) — Basic Average Shares: 47766338.00
CLYM income_statement (annual, 2025-12-31) — Basic EPS: -0.88
CLYM income_statement (quarterly, 2025-12-31) — Basic EPS: -0.26
CLYM cash_flow (annual, 2025-12-31) — Beginning Cash Position: 87229000.00
CLYM cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 25803000.00
CLYM cash_flow (annual, 2025-12-31) — Capital Expenditure: -186000.00
CLYM balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 541000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 541000.00
CLYM balance_sheet (annual, 2025-12-31) — Capital Stock: 5000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Capital Stock: 5000.00
CLYM balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 35685000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 35685000.00
CLYM balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 101080000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 101080000.00
CLYM balance_sheet (annual, 2025-12-31) — Cash Equivalents: 35685000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 35685000.00
CLYM cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -21000.00
CLYM cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -21000.00
CLYM cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 2833000.00
CLYM cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 25538000.00
CLYM cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -54356000.00
CLYM cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -15635000.00
CLYM cash_flow (annual, 2025-12-31) — Change In Account Payable: 1564000.00
CLYM cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 1792000.00
CLYM cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 372000.00
CLYM cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 220000.00
CLYM cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -1514000.00
CLYM cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 0.00
CLYM cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -207000.00
CLYM cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -39000.00
CLYM cash_flow (annual, 2025-12-31) — Change In Payable: 1564000.00
CLYM cash_flow (quarterly, 2025-12-31) — Change In Payable: 1792000.00
CLYM cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 1936000.00
CLYM cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 2012000.00
CLYM cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -816000.00
CLYM cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -706000.00
CLYM cash_flow (annual, 2025-12-31) — Change In Working Capital: -601000.00
CLYM cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 1267000.00
CLYM cash_flow (annual, 2025-12-31) — Changes In Cash: -51544000.00
CLYM cash_flow (quarterly, 2025-12-31) — Changes In Cash: 9882000.00
CLYM balance_sheet (annual, 2025-12-31) — Common Stock: 5000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Common Stock: 5000.00
CLYM balance_sheet (annual, 2025-12-31) — Common Stock Equity: 160475000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 160475000.00
CLYM cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
CLYM cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
CLYM balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 4400000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 4400000.00
CLYM balance_sheet (annual, 2025-12-31) — Current Assets: 105849000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Current Assets: 105849000.00
CLYM balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 256000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 256000.00
CLYM balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 256000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 256000.00
CLYM balance_sheet (annual, 2025-12-31) — Current Liabilities: 6984000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 6984000.00
CLYM cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 97000.00
CLYM cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 30000.00
CLYM cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 97000.00
CLYM cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 30000.00
CLYM income_statement (annual, 2025-12-31) — Diluted Average Shares: 47766338.00
CLYM income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 47766338.00
CLYM income_statement (annual, 2025-12-31) — Diluted EPS: -0.88
CLYM income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.26
CLYM income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -59851000.00
CLYM income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -17516000.00
CLYM income_statement (annual, 2025-12-31) — EBIT: -67883000.00
CLYM income_statement (quarterly, 2025-12-31) — EBIT: -19296000.00
CLYM income_statement (annual, 2025-12-31) — EBITDA: -67786000.00
CLYM income_statement (quarterly, 2025-12-31) — EBITDA: -19266000.00
CLYM cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 0.00
CLYM cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 0.00
CLYM cash_flow (annual, 2025-12-31) — End Cash Position: 35685000.00
CLYM cash_flow (quarterly, 2025-12-31) — End Cash Position: 35685000.00
CLYM cash_flow (annual, 2025-12-31) — Financing Cash Flow: -21000.00
CLYM cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -21000.00
CLYM cash_flow (annual, 2025-12-31) — Free Cash Flow: -54542000.00
CLYM cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -15635000.00
CLYM income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -291000.00
CLYM income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -46000.00
CLYM balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 435000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 435000.00
CLYM income_statement (annual, 2025-12-31) — General And Administrative Expense: 21170000.00
CLYM income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 5558000.00
CLYM balance_sheet (annual, 2025-12-31) — Gross PPE: 793000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Gross PPE: 793000.00
CLYM income_statement (annual, 2025-12-31) — Interest Income: 8323000.00
CLYM income_statement (annual, 2025-12-31) — Interest Income Non Operating: 8323000.00
CLYM balance_sheet (annual, 2025-12-31) — Invested Capital: 160475000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Invested Capital: 160475000.00
CLYM cash_flow (annual, 2025-12-31) — Investing Cash Flow: 2833000.00
CLYM cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 25538000.00
CLYM balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 59572000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 59572000.00
CLYM balance_sheet (annual, 2025-12-31) — Investments And Advances: 59572000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 59572000.00
CLYM cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
CLYM cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
CLYM balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 285000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 285000.00
CLYM balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 285000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 285000.00
CLYM cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
CLYM cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
CLYM cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 18000.00
CLYM cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -5000.00
CLYM income_statement (annual, 2025-12-31) — Net Income: -59851000.00
CLYM income_statement (quarterly, 2025-12-31) — Net Income: -17516000.00
CLYM income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -59851000.00
CLYM income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -17516000.00
CLYM income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -59851000.00
CLYM income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -17516000.00
CLYM income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -59851000.00
CLYM income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -17516000.00
CLYM income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -59851000.00
CLYM income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -17516000.00
CLYM cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -59851000.00
CLYM cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -17516000.00
CLYM income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -59851000.00
CLYM income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -17516000.00
CLYM income_statement (annual, 2025-12-31) — Net Interest Income: 8323000.00
CLYM cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 3019000.00
CLYM cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 25538000.00
CLYM income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 8323000.00
CLYM cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -86000.00
CLYM balance_sheet (annual, 2025-12-31) — Net PPE: 793000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Net PPE: 793000.00
CLYM cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -186000.00
CLYM cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 0.00
CLYM balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 160475000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 160475000.00
CLYM income_statement (annual, 2025-12-31) — Normalized EBITDA: -67495000.00
CLYM income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -19220000.00
CLYM income_statement (annual, 2025-12-31) — Normalized Income: -59560000.00
CLYM income_statement (quarterly, 2025-12-31) — Normalized Income: -17470000.00
CLYM cash_flow (annual, 2025-12-31) — Operating Cash Flow: -54356000.00
CLYM cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -15635000.00
CLYM cash_flow (annual, 2025-12-31) — Operating Gains Losses: 18000.00
CLYM cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -5000.00
CLYM income_statement (annual, 2025-12-31) — Operating Income: -67883000.00
CLYM income_statement (quarterly, 2025-12-31) — Operating Income: -19296000.00
CLYM income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
CLYM income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
CLYM balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 47766338.00
CLYM balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 47766338.00
CLYM balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 59000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 59000.00
CLYM balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 435000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 435000.00
CLYM income_statement (annual, 2025-12-31) — Other Gand A: 21170000.00
CLYM income_statement (quarterly, 2025-12-31) — Other Gand A: 5558000.00
CLYM income_statement (annual, 2025-12-31) — Other Income Expense: -291000.00
CLYM income_statement (quarterly, 2025-12-31) — Other Income Expense: -6543000.00
CLYM cash_flow (annual, 2025-12-31) — Other Non Cash Items: 201000.00
CLYM cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 57000.00
CLYM balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 1530000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 1530000.00
CLYM balance_sheet (annual, 2025-12-31) — Other Properties: 793000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Other Properties: 793000.00
CLYM balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 65395000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 65395000.00
CLYM balance_sheet (annual, 2025-12-31) — Payables: 2269000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Payables: 2269000.00
CLYM balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 6669000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 6669000.00
CLYM balance_sheet (annual, 2025-12-31) — Prepaid Assets: 4769000.00
CLYM balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 4769000.00
CLYM income_statement (annual, 2025-12-31) — Pretax Income: -59851000.00